i3 Health Podcast Titelbild

i3 Health Podcast

i3 Health Podcast

Von: i3 Health
Jetzt kostenlos hören, ohne Abo

Über diesen Titel

i3 Health’s mission is to enhance the proficiency of the interprofessional healthcare team by providing evidence-based, fair-balanced CME/NCPD/CPE-approved activities that address identified professional practice gaps and unmet educational needs.All rights reserved Wissenschaft
  • Additional Advances in ALS Research and Clinical Trials With Richard S. Bedlack, MD, PhD, MS
    Feb 10 2026
    The ALS treatment landscape is shifting faster than ever, with emerging clinical trial data and advances in gene‑targeted therapies reshaping how healthcare professionals think about disease management and patient support. Now, with encouraging new results from clinical trials and the growing influence of AI‑driven drug discovery, Richard S. Bedlack, MD, PhD, of Duke University School of Medicine, and chair of i3 Health's activity, "Slowing Disease Progression and Optimizing Quality of Life for Patients with ALS, returns to highlight the latest developments that are already informing clinical practice—and bringing renewed optimism to both clinicians and the patients they serve. Click here to view the full activity and claim your free credit: https://bit.ly/4qbRoXh
    Mehr anzeigen Weniger anzeigen
    12 Min.
  • EXPIRING SOON! Schizophrenia Update: Module 4: Applying the Latest Therapeutic Advances to Patient-Centered Care
    Feb 2 2026
    Effective schizophrenia management requires a holistic, patient-centered approach tailored to the individual’s unique needs. This final module focuses on integrating evidence-based strategies with shared decision-making to foster recovery. If you missed any previous parts of this series, be sure to listen to Modules 1 through 3 to gain a comprehensive update on the latest research and treatment landscape. Note: This podcast expires on 2/17. Click the link below to claim your CME/NCPD/CPE credit. bit.ly/4oflWWZ
    Mehr anzeigen Weniger anzeigen
    18 Min.
  • EXPIRING SOON! Schizophrenia Update: Module 3: Emerging Treatments for Cognitive Symptoms
    Feb 2 2026
    Cognitive impairment is a core feature of schizophrenia that contributes heavily to long-term disability. In Module 3, discover current and emerging pharmacologic treatments designed to target cognitive symptoms, alongside psychosocial and lifestyle interventions that enhance functioning. To complete the series, continue to Module 4 for a deep dive into applying these advances to patient-centered care. Note: This podcast expires on 2/17. Click the link below to claim your CME/NCPD/CPE credit. bit.ly/47fkz4p
    Mehr anzeigen Weniger anzeigen
    19 Min.
Noch keine Rezensionen vorhanden